This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Biogen Ma Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Ellen Cahir-McFarland
Introduction
Ellen Cahir-McFarland is a notable inventor based in Cambridge, MA (US). She has made significant contributions to the field of medicine, particularly in the treatment of hypercholesterolemia. Her innovative approach has led to the development of a unique method for lowering elevated cholesterol plasma levels.
Latest Patents
Ellen holds 1 patent for her work titled "Methods for treating hypercholesterolemia." This patent discloses a method of lowering elevated cholesterol plasma levels in a subject. It also outlines a method of treating hypercholesterolemia by administering an effective amount of Compound 1 or a pharmaceutically acceptable salt thereof, without the use of a cholesterol-lowering drug.
Career Highlights
Ellen Cahir-McFarland is currently associated with Biogen MA Inc., where she continues to advance her research and innovations. Her work has been instrumental in developing new therapeutic strategies for managing cholesterol levels, which is crucial for preventing cardiovascular diseases.
Collaborations
Ellen collaborates with Shibeshih Belachew, contributing to the advancement of their shared goals in medical research and innovation.
Conclusion
Ellen Cahir-McFarland's contributions to the field of medicine through her innovative patent for treating hypercholesterolemia highlight her role as a leading inventor. Her work continues to impact the healthcare industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile